CASE NAME

Adriane Sack v. Bodywell USA, Inc.

CASE NO.

3:26-cv-02838-N

JURISDICTION

United States District Court for the Northern District of Texas, Dallas Division

FILED ON

08/24/26

CLASS DEFINTION

According to the complaint, the proposed nationwide and Texas classes consist of consumers who purchased Bodywell products marketed as providing protection from electromagnetic fields.

SUMMARY

According to the complaint, plaintiff Adriane Sack brings a putative nationwide class action against Bodywell USA, Inc., alleging that the company falsely markets and sells its “BioChip” and related products as providing meaningful protection from electromagnetic fields (EMFs), when in reality they allegedly offer no EMF protection at all.

The lawsuit contends that Bodywell promotes the BioChip as a scientifically proven device that reduces radiation exposure by up to 80% and delivers health benefits, while internal and fine-print statements on the company’s own website allegedly contradict and undercut these promises. The plaintiff seeks to represent purchasers across the United States and in Texas who allegedly relied on these representations, asserting claims for common-law fraud and multiple violations of the Texas Deceptive Trade Practices Act (DTPA), and seeking injunctive relief, damages, and enhanced punitive and treble damages.

ALLEGATIONS

The complaint alleges that Bodywell USA, Inc. manufactures, markets, and sells a product called the “BioChip” as a means of protecting consumers from exposure to electromagnetic fields emitted by electronic devices such as cell phones and other wireless products. According to the lawsuit, Bodywell represents that the BioChip is capable of providing significant EMF protection, including claims that it can reduce radiation exposure by “up to 80%,” and that it offers various associated health benefits.

The lawsuit asserts that, despite these bold marketing statements, the BioChip is in fact nothing more than a thin piece of aluminum that does not deliver the advertised EMF protection. According to the complaint, Bodywell’s marketing materials, website, and product packaging create the impression that the BioChip is supported by scientific evidence and offers real, measurable protection from EMFs. The plaintiff alleges that consumers are led to believe that purchasing and using the BioChip will meaningfully reduce their exposure to harmful radiation and improve their well-being.

At the same time, the complaint contends that internal and fine-print statements on Bodywell’s own website contradict these public marketing promises. According to the plaintiff, these less prominent disclosures suggest that Bodywell’s EMF protection claims are overstated or unsupported, and that the product does not, in fact, provide the level of radiation reduction prominently advertised. The lawsuit alleges that these contradictions demonstrate that Bodywell knew, or should have known, that its public claims were misleading or false.

The plaintiff, Adriane Sack, claims that she and other consumers purchased Bodywell’s BioChip and related products in reliance on the company’s representations about EMF protection and health benefits. The complaint alleges that consumers paid a premium price for these products because they believed they were obtaining a scientifically backed safety device, when in reality they allegedly received only a simple aluminum component with no meaningful EMF protection. According to the lawsuit, had consumers known the true nature of the product and the alleged contradictions in Bodywell’s own statements, they would not have purchased the products or would not have paid as much for them.

On behalf of herself and similarly situated consumers nationwide and in Texas, the plaintiff brings claims for common-law fraud, asserting that Bodywell intentionally or recklessly misrepresented and concealed material facts regarding the BioChip’s capabilities. The complaint further alleges multiple violations of the Texas Deceptive Trade Practices Act, including false, misleading, and deceptive acts or practices and alleged misrepresentations about the characteristics and benefits of the product.

The lawsuit seeks certification of nationwide and Texas classes of purchasers of Bodywell’s BioChip and related products marketed as providing EMF protection. The relief requested includes injunctive relief to stop the allegedly deceptive marketing practices, restitution or other monetary relief to compensate consumers for their purchases, and additional damages available under Texas law. According to the complaint, the plaintiff seeks punitive and treble damages based on Bodywell’s allegedly knowing and intentional conduct in promoting a product that purportedly does not perform as claimed.

Overall, the complaint portrays Bodywell’s marketing of the BioChip as a coordinated effort to capitalize on consumer concerns about EMF exposure by offering a product that, according to the plaintiff, provides no real protection, while using scientific-sounding claims and assurances that are allegedly contradicted by the company’s own less conspicuous statements.

Complaint